Tuberculosis Infection Scholarly Peer-Review Journal
TB bacteria can sleep in the body without making you sick. this is often called latent TB infection. In most of the people who inhale TB bacteria and become infected, the body is in a position to fight the bacteria to prevent them from growing. People with latent TB infection:
• Have no symptoms
• Don’t feel sick
• Can’t spread TB bacteria to others
• Usually have a positive TB diagnostic test reaction or positive TB biopsy
• May develop TB disease if they are doing not receive treatment for latent TB infection
Many people who have latent TB
infection never develop TB disease. In these people, the TB bacteria remain inactive for a lifetime without causing disease. But in people , especially people that have a weak system , the bacteria become active, multiply, and cause TB disease. TB Disease: TB bacteria become active if the system can’t stop them from growing. When TB bacteria are active (multiplying in your body), this is often called TB disease. People with TB disease are sick. they'll even be ready to spread the bacteria to people they spend time with a day . many of us who have latent TB
infection never develop TB disease. Some people develop TB disease soon after becoming infected (within weeks) before their system can fight the TB bacteria. people may get sick years later when their system becomes weak for an additional reason. For people whose immune systems are weak, especially those with HIV infection, the danger of developing TB disease is far above for people with normal immune systems.
High Impact List of Articles
-
Exploring standards for industrializing human induced pluripotent stem cells
Hidemasa Kato*, Keiko Hiraki-Kamon, Masamitsu Eitoku, Hidenori Kiyosawa, Cindy Neeley & Yasushi Okazaki
Perspective Article: Pharmaceutical Bioprocessing
-
Exploring standards for industrializing human induced pluripotent stem cells
Hidemasa Kato*, Keiko Hiraki-Kamon, Masamitsu Eitoku, Hidenori Kiyosawa, Cindy Neeley & Yasushi Okazaki
Perspective Article: Pharmaceutical Bioprocessing
-
Antibody immunogenicity: does bioprocessing hold all the answers?
Herman Waldmann
Editorial: Pharmaceutical Bioprocessing
-
Antibody immunogenicity: does bioprocessing hold all the answers?
Herman Waldmann
Editorial: Pharmaceutical Bioprocessing
-
Special Focus: an Omics approach to Chinese hamster ovary based pharmaceutical bioprocessing
Colin Clarke* and Kelvin H Lee
Short Report: Pharmaceutical Bioprocessing
-
Special Focus: an Omics approach to Chinese hamster ovary based pharmaceutical bioprocessing
Colin Clarke* and Kelvin H Lee
Short Report: Pharmaceutical Bioprocessing
-
Study sheds light on nonessential amino acids in cell culture
Jessica Thorne
News and Views: Pharmaceutical Bioprocessing
-
Study sheds light on nonessential amino acids in cell culture
Jessica Thorne
News and Views: Pharmaceutical Bioprocessing
-
3D scaffolds in tissue engineering and regenerative medicine: beyond structural templates?
Tierney GB Deluzio, Dawit G Seifu and Kibret Mequanint*
Review Article: Pharmaceutical Bioprocessing
-
3D scaffolds in tissue engineering and regenerative medicine: beyond structural templates?
Tierney GB Deluzio, Dawit G Seifu and Kibret Mequanint*
Review Article: Pharmaceutical Bioprocessing
-
Driving value through biopharmaceutical manufacturing
Harpreet Dhaliwal, Jorg Thommes
Editorial: Pharmaceutical Bioprocessing
-
Driving value through biopharmaceutical manufacturing
Harpreet Dhaliwal, Jorg Thommes
Editorial: Pharmaceutical Bioprocessing
Relevant Topics in Clinical